Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety
about
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionIs wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityBlocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesAdvances in HIV microbicide developmentIn vitro surfactant structure-toxicity relationships: implications for surfactant use in sexually transmitted infection prophylaxis and contraceptionLignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmissionPolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionThe Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal ApplicationsDrug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory TrialEfficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsStructure activity relationship of dendrimer microbicides with dual action antiviral activityIntravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.Advances in the Development of Microbicides for the Prevention of HIV Infection.A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safetyIn vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.Topical microbicides and HIV prevention in the female genital tractIn vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.Minocycline down-regulates topical mucosal inflammation during the application of microbicide candidatesIn vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge modelFemale genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Topical microbicides to prevent the transmission of HIV: formulation gaps and challengesTopical prophylaxis for HIV prevention in women: becoming a reality.Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies.Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.The use of preexposure treatments for HIV prophylaxisOptimizing siRNA delivery to the genital mucosasiRNA-based topical microbicides targeting sexually transmitted infections.Microbicides for HIV prevention.Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.
P2860
Q21090718-17AE91E5-FC3E-46B7-9F64-833CDDE7FB68Q21133918-1F9E641E-BA96-4EED-960E-2FA85B3FCC7CQ26774878-36BD03D6-5FDF-4405-8999-CDC34BC65282Q26852858-F880D602-1F08-48B2-BBE0-3D1130581D14Q28478153-D79D6820-CA76-4A87-BA1B-90B7F710C3A0Q28482818-B741ECDF-88AD-457E-8AAA-C1A1A75BF178Q28489042-152683B4-DB7F-45C0-8010-EB7C3723D4A5Q28546014-DD464316-B39E-4DF3-8FE0-1BB07CBEBD54Q28552171-0A2F18D5-6F09-42D8-AE8B-15389E808F23Q28729936-FACA5DE6-A2CB-475B-9736-34DCFB8A79B2Q28749211-631B1193-7A6B-41EA-A5C0-A74D81285FAFQ28749596-F05FB338-8B57-401A-8E13-92447A5E802AQ33531770-AC77F5A9-0FA3-433C-B351-4624C7359C68Q33662836-2D4C865F-268C-444C-A363-A75B664190F4Q33750747-A51D4F94-520F-4234-BAB5-F5997A1D7B29Q33762924-331FD8D7-6C8A-416C-B1E5-E3161FAF3D53Q33808638-CECC49EC-D7E7-4DFA-B782-08869ABCE2A1Q33889911-FDC5A904-96B0-4B59-98B5-251020C5567CQ33978803-02C2AB7F-A2F4-4DF5-8C05-3598EDA35C2BQ34075698-5A15CC66-4724-4E91-983F-63C1886DA39CQ34078011-AD0C9C47-5D06-46CD-8AFB-8290229172ACQ34086820-4E13346C-E453-4203-BFD5-07FEBF97740BQ34309533-31C0F262-35A4-45EE-B85A-999C0F3D7D0AQ34353780-DF5BFE10-4E8A-4F20-993C-BFF2E740A3A6Q34384880-10466A7E-6257-4CCE-A6E8-8960F87BB003Q34387113-773291D2-29F7-4349-A26A-ADA58FD87EAFQ34680240-6DB6EA0C-F93F-4005-9BD1-F2405593A00DQ35009798-E800418E-AB1D-4887-9E64-F1234FB002BAQ35031133-2C176FE5-A3E7-42EF-A9C0-33ECB2E0733BQ35042602-CA5E51E3-FEA3-4E6B-BE36-E12062EAA17FQ35208283-E764FEB0-3378-41EC-9612-692B3B515D56Q35256845-7C32BDB5-3211-433E-A356-3779E9D2603DQ35656128-07CA0C75-C5CE-4854-9DEF-D203F72CC7E1Q35666495-A0C98172-038E-4CD1-BEEB-145C116395A4Q35760180-7E6DE6CB-7015-4F37-A5EE-30C3DCAFF517Q35766249-2F0FFC0D-B496-4752-8F88-068DDECD429EQ35766254-17390DE9-2BB5-4F2F-84BC-C3FF2B6DF7AFQ35770899-32C66BB1-D1D9-4CA4-9751-37C27000392BQ35808786-B7CD543D-1701-42A5-B070-BD06D59D696BQ35905458-C5C7DE44-F590-4CB0-98F4-0D9B567D097A
P2860
Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Disruption of tight junctions ...... n: model of microbicide safety
@ast
Disruption of tight junctions ...... n: model of microbicide safety
@en
type
label
Disruption of tight junctions ...... n: model of microbicide safety
@ast
Disruption of tight junctions ...... n: model of microbicide safety
@en
prefLabel
Disruption of tight junctions ...... n: model of microbicide safety
@ast
Disruption of tight junctions ...... n: model of microbicide safety
@en
P2093
P2860
P356
P1476
Disruption of tight junctions ...... n: model of microbicide safety
@en
P2093
Betsy C Herold
Esmeralda Guzman
Esra Fakioglu
Marla J Keller
Mohak Mhatre
Natalia Cheshenko
Pedro M M Mesquita
Sarah S Wilson
P2860
P304
P356
10.1086/600867
P407
P577
2009-08-01T00:00:00Z